Close Menu

NEW YORK (GenomeWeb) — Pacific Biosciences announced this week that it has reached the final developmental milestone of its commercialization and licensing agreement with Roche. The agreement, originally announced in September, entitles Roche to commercialize and sell clinical diagnostics products developed by PacBio based on the company's Single Molecule, Real Time technology. With the final milestone achieved, Roche has paid PacBio an additional $20 million.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

23andMe and Airbnb have partnered to offer "heritage travel," according to Venture Beat.

China may include regulations protecting genes and embryos in its update of its civil code, Nature News reports.

In Nature this week: exome sequence analysis of individuals with type 2 diabetes, genomic prediction of maize yield across environments, and more.

NPR reports on efforts to engineer bacteriophages to destroy antibiotic-resistance bacteria.